Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 10 fludarabine 7 pomalidomide 5 pembrolizumab 5 Dexamethasone 5 daratumumab 4 obinutuzumab 3 glofitamab 3 fludarabine phosphate 3 abemaciclib 3 Rituximab 3 Melphalan 3 Immunotherapy, Adoptive 3 Etoposide 3 Bortezomib 3 zanubrutinib 2 venetoclax 2 tocilizumab 2 pirtobrutinib 2 palbociclib 2 cemiplimab 2 blinatumomab 2 Temozolomide 2 Sirolimus 2 Oxaliplatin 2 Nivolumab 2 Mesna 2 Letrozole 2 Injections 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × GDC-0084 × 30 days × Clear all

NCT03970447 2026-06-03

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡